SCHEMBL7984677

SCHEMBL7984677

O=c1[nH]c(-c2cccc(O)c2)nc2ncn(Cc3ccccc3F)c12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.39
HSD17B13 Q7Z5P4 1/20 0.38
KMT2A Q03164 2/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
MEN1 O00255 1/20 0.37
RNASEL Q05823 1/20 0.36
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988742 0.90 LMNA (0.42) TP53LMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL7985420 0.89 TP53 (0.42) TP53LMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL7987219 0.88 ALDH1A1 (0.45) TP53LMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL7974198 0.88 LMNA (0.41) TP53LMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL7985332 0.85 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2HPGDKMT2ARNASEL
SCHEMBL7988405 0.85 HPGD (0.49) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL7985609 0.85 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HPGDHSD17B13KMT2A
SCHEMBL7986753 0.84 TNKS (0.43) TP53LMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL7991634 0.84 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HPGDHSD17B13KMT2A
SCHEMBL7984682 0.84 PDE4A (0.39) TP53LMNAPOLBALDH1A1HSD17B13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed